A negative correlation between hyperalgesia and analgesia in patients with chronic radicular pain: Is hydromorphone therapy a double-edged sword?

Pain Physician

Volumn 16, Issue 1, 2013, Pages 65-76

  Suzan, Erica ^a,b   Eisenberg, Elon ^a,b   Treister, Roi ^a,b,c   Haddad, May ^b,c   Pud, Dorit ^c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Institute of Pain Medicine   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

Analgesia; Disc herniation; Hydromorphone; Neuropathic pain; Opioid induced hyperalgesia (OIH); Radiculopathy

Indexed keywords

BISACODYL; HYDROMORPHONE; LACTULOSE; OPIATE; PARACETAMOL;

ADULT; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CHRONIC PAIN; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; HUMAN; HYPERALGESIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; OSWESTRY DISABILITY INDEX; PAIN ASSESSMENT; PAIN THRESHOLD; PROSPECTIVE STUDY; QUESTIONNAIRE; RADICULAR PAIN; SCORING SYSTEM; VISUAL ANALOG SCALE;

ADULT; AGED; ANALGESICS, OPIOID; CHRONIC PAIN; FEMALE; HUMANS; HYDROMORPHONE; HYPERALGESIA; MALE; MIDDLE AGED; RADICULOPATHY; YOUNG ADULT;

EID: 84872805586     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Eisenberg E, McNicol E, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials. JAMA 2005; 293:3043-3052.
2. MT. Neuroexcitatory effects of morphine and hydromorphone: Evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 2000; 27:524-528.
3. Juni A, Klein G, Kowalczyk B, Ragnauth A, Kest B. Sex differences in hyperalgesia during morphine infusion: Effect of gonadectomy and estrogen treatment. Neuropharmacology 2008; 54:1264-1270.
4. Lacroix-Fralish ML, Mogil JS. Progress in genetic studies of pain and analgesia. Annu Rev Pharmacol Toxicol 2009; 49:97-121.
5. Angst MS, Clark JD. Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology 2006; 104:570-587.
6. Mao J, Price DD, Mayer DJ. Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C. J Neurosci 1994; 14:2301-2312.
7. Laulin JP, Celerier E, Larcher A, Le Moal M, Simonnet G. Opiate tolerance to daily heroin administration: An apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 1999; 89:631-636.
8. Célèrier E, Laulin JP, Corcuff JB, Le Moal M, Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: A sensitization process. J Neurosci 2001; 21:4074-4080.
9. Fishbain DA, Cole B, Lewis JE, Gao J, Rosomoff RS. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med 2009; 10:829-839.
10. Cooper DW, Lindsay SL, Ryall DM, Kokri MS, Eldabe SS, Lear GA. Does intrathecal fentanyl produce acute cross-tolerance to i.v. morphine? Br J Anaesth 1997; 78:311-313.
11. Guignard B, Bossard AE, Coste C, Sessler DI, Lebraul, C, Alfonsi P, Fletcher D, Chauvin M. Acute opioid tolerance: Intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000; 93:409-417.
12. Joly V, Richebe P, Guignard B, Fletcher D, Maurette P, Sessler DI, Chauvin M. Remifentanil-induced postoperative hyperalgesia and its prevention with smalldose ketamine. Anesthesiology 2005; 103:147-155.
13. Song JW, Lee YW, Yoon KB, Park SJ, Shim YH. Magnesium sulfate prevents remifentanil-induced postoperative hyperalgesia in patients undergoing thyroidectomy. Anesth Analg 2011; 113:390-397.
14. Compton P, Charuvastra VC, Ling W. Pain intolerance in opioid-maintained former opiate addicts: Effect of intermediate-acting maintenance agent. Drug Alcohol Depend 2001; 63:139-146.
15. Pud D, Cohen D, Lawental E, Eisenberg E. Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy patients. Drug Alcohol Depend 2006; 82:218-223.
16. Hay JL, White JM, Bochner F, Somogyi AA, Semple TJ, Rounsefell B. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J Pain 2009; 10:316-322.
17. Reznikov I, Pud D, Eisenberg E. Oral opioid administration and hyperalgesia in patients with cancer or chronic nonmalignant pain. Br J Clin Pharmacol 2005; 60:311-318.
18. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain 2006; 7:43-48.
19. Ram KC, Eisenberg E, Haddad M, Pud D. Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain - New perspective of opioid-induced hyperalgesia. Pain 2008; 139:431-438.
20. Chen L, Malarick C, Seefeld L, Wang S, Houghton M, Mao J. Altered quantitative sensory testing outcome in patients with opioid therapy. Pain 2009; 143:65-70.
21. Wang H, Fischer C, Chen G, Weinsheimer N, Gantz S, Schiltenwolf M. Does intermediate-term opioid therapy reduce pain sensitivity of patients with chronic low back pain? Evidence from quantitative sensory testing. Pain Physician 2012; 15:135-143.
22. Chu LF, D'Arcy N, Brady C, Zamora AK, Young CA, Kim JE, Clemenson AM, Angst MS, Clark JD. Analgesic tolerance without demonstrable opioid-induced hyperalgesia: A double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain. Pain 2012; 153:1583-1592.
23. Hooten WM, Mantilla CB, Sandroni P, Townsend CO. Associations between heat pain perception and opioid dose among patients with chronic pain undergoing opioid tapering. Pain Med 2010; 11:1587-1598.
24. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 2008; 70:1630-1635.
25. Compton P, Charuvastra VC, Kintaudi K, Ling W. Pain responses in methadonemaintained opioid abusers. J Pain Symptom Manage 2000; 20:237-245.
26. Compton P, Athanasos P, Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: A preliminary study. J Pain 2003; 4:511-519.
27. Roland M, Fairbank J. The Roland-Morris disability questionnaire and the Oswestry disability questionnaire. Spine (Phila Pa 1976) 2000; 25:3115-3124.
28. Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain 2009; 144:35-42.
29. Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987; 13:293-308.
30. Bendtsen L, Jensen R, Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch Neurol 1996; 53:373-376.
31. Svensson P, List T, Hector G. Analysis of stimulus-evoked pain in patients with myofascial temporomandibular pain disorders. Pain 2001; 92:399-409.
32. Wanigasekera V, Lee MC, Rogers R, Hu P, Tracey I. Neural correlates of an injury- free model of central sensitization induced by opioid withdrawal in humans. J Neurosci 2011; 31:2835-2842.
33. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003; 106:49-57.
34. Hood DD, Curry R, Eisenach JC. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg 2003; 97:805-810.
35. Petersen KL, Jones B, Segredo V, Dahl JB, Rowbotham MC. Effect of remifentanil on pain and secondary hyperalgesia associated with the heat-capsaicin sensitization model in healthy volunteers. Anesthesiology 2001; 94:15-20.
36. VonVoigtlander PF, Lewis RA. A withdrawal hyperalgesia test for physical dependence: Evaluation of mu and mixedpartial opioid agonists. J Pharmacol Methods 1983; 10:277-282.
37. Laulin JP, Larcher A, Célèrier E, Le Moal M, Simonnet G. Intermediate-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur J Neurosci 1998; 10:782-785.
38. Célèrier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, Simonnet, G. Intermediate-lasting hyperalgesia induced by fentanyl in rats: Preventive effect of ketamine. Anesthesiology 2002; 92:465-472.
39. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2006; 171:686-691.
40. Khoromi S, Cui L, Nackers L, Max MB. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain 2007; 130:66-75.
41. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr, D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003; 348:1223-1232.